ArticleOsteoarthritis imaging2025
Radiomic features of infrapatellar fat pad are associated with knee symptoms and radiographic post-traumatic osteoarthritis at 10+ years after anterior cruciate ligament reconstruction.
Article in Osteoarthritis imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
16 authors.
Funding
Abstract
Objective: The infrapatellar fat pad (IPFP) has been identified as a potential agent in joint degeneration leading to post-traumatic osteoarthritis (PTOA) in patients suffering from anterior cruciate ligament (ACL) injury. We leveraged machine learning and radiomics methods on knee MRI taken at ten-year follow-up post-ACL reconstruction to associate IPFP with knee symptoms and radiographic PTOA. Design: In this cross-sectional study, the multi-site NIH-funded MOON nested Onsite cohort was followed up at ten years to obtain 3D MRI radiomics and patient-reported outcome measures (PROM). We identified the features with two radiomics-based classifiers that can detect, respectively, knee symptoms based on PROM data or radiographic PTOA based on Kellgren-Lawrence grade. Results: We identified 29 radiomics features describing IPFP texture heterogeneity, volume, and signal intensity. For knee symptom detection, models constructed from radiomics achieved an AUROC of 0.76 [95 % CI, 0.65, 0.87], and 0.74 on cross-validation and the test set, respectively. For radiographic PTOA detection, models combining radiomics with clinical features achieved an AUROC of 0.82 [95 % CI, 0.74, 0.92] and 0.79 on cross-validation and the test set, respectively. Increased IPFP texture heterogeneity, larger volume, and increased signal intensity were linked to higher likelihood of knee symptoms and radiographic PTOA. Conclusion: Radiomics features describing IPFP intensity, morphology, and texture achieve fair to moderate performance in discriminating PTOA-positive from PTOA-negative patients, defined either symptomatically or radiographically. These features describe the relationship between the IPFP and PTOA and are candidates for prognostic models or diagnostic scores that would link knee imaging to patient symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.